Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0001104659-25-065844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-03 | 2025-07-02 | RYTM | Garfield Alastair | CSO | S - Sale+OE | $64.81 | -1,319 | 3,126 | -30% | -$85.5K |
| D | 2025-07-03 | 2025-07-01 | RYTM | Garfield Alastair | CSO | M - OptEx | — | +4,445 | 4,445 | New | — |
| D | 2025-07-03 | 2025-07-01 | RYTM | Garfield Alastair | CSO | M - OptEx | $0.00 | -4,445 | 13.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-02 | S | D | 1,313 | $64.81 | 3,132 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-02 | S | D | 6 | $64.60 | 3,126 | D | — | — | |
| 3 | Common | Common Stock | 2025-07-01 | M | A | 4,445 | — | 4,445 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 4 | Derivative | Restricted Stock Units | 2025-07-01 | M | D | 4,445 | $0.00 | 13,333 | D | — · — to — | 4,445 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. |